Innovent Biologics raises $25M series B

Chinese mAb manufacturer Innovent Biologics Inc. (Suzhou, China) raised $25 million in a series B round from Lilly Asia Ventures; Fidelity Biosciences; and Fidelity Growth Partners Asia. Innovent is a...